Science2 days ago
Roche Unveils Promising Data for Giredestrant in Breast Cancer Therapy
Roche has announced significant findings regarding its oral selective estrogen receptor degrader (SERD), giredestrant, in the treatment of early-stage breast cancer. The results, presented at the...